Adaptive Biotechnologies Corp Clinical Trials
Determine Adaptive Biotechnologies Corp go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.
A sample of Adaptive Biotechnologies Corp Clinical Trials data
| Trial Title | Trial Identifier | Drug Name | Therapy Area | Indication | Trial Phase | Trial Status | Sponsor |
|---|---|---|---|---|---|---|---|
| Deserunt mollit sunt Lorem | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Pfizer Inc |
| Optimizing Ctdna-based Mrd Assessment in Dlbcl, Mcl, and Fl Patients Undergoing Car Therapy | GDCT0449147 | CD19 chimeric antigen receptor T-cells; undisclosed chemotherapy | Oncology | Diffuse Large B-Cell Lymphoma; Follicular Lymphoma; Mantle Cell Lymphoma; Primary Mediastinal B-Cell Lymphoma | Phase IV | Planned | Adaptive Biotechnologies Corp |
| A Phase I/II, Open Label, Dose Escalation Study to Determine Safety and Immunogenicity of Two (Prophylactic) COVID 19 DNA Vaccine Candidates (VB10.2129 [C1], a RBD Candidate and VB10.2210 [C2], a T Cell Candidate), in Healthy Adult Volunteers | GDCT0434188 | VB-2129; VB-2210 | Infectious Disease | Coronavirus Disease 2019 (COVID-19) | Phase I/II | Ongoing, not recruiting | Nykode Therapeutics ASA |
| A Study to Compare the Efficacy and Safety of a Combined Regimen of Venetoclax and Obinutuzumab Versus Fludarabine, Cyclophosphamide, and Rituximab (FCR)/ Bendamustine and Rituximab (BR) in Fit Patients with Previously Untreated Chronic Lymphocytic Leukemia (CLL) Without Del (17P) or TP53 Mutation (CRISTALLO) | GDCT0380523 | obinutuzumab | Oncology | Chronic Lymphocytic Leukemia (CLL) | Phase III | Ongoing, recruiting | F. Hoffmann-La Roche Ltd |
Feature
GlobalData’s Clinical Trials database (CTDB) is a highly comprehensive source of Clinical Trials.
The database covers planned, ongoing, completed and terminated/suspended/withdrawn clinical trials.
Clinical Trials database provides intelligence on global clinical trials for all indications. The data is sourced from:
- 250+ clinical trial registries
- 200+ scientific and investor conferences, company pipelines, press releases, and SEC filings.
Benefit
The Clinical Trials database collects information on various parameters to provide a Clinical Trial overview as well as Clinical Trial details, Drug details, Patient details, Trial Results, Location(s)/Sponsor(s) and Contact Detail(s).
Access:
- Detailed trial information.
- Drug information.
- Patient information, including inclusion and exclusion criteria.
- Trial results, as reported in the public domain.
- Biomarkers used for patient stratification/selection & outcome measures.
- Enrolment parameters.
- Investigators involved in clinical trials.
- Trials sites and locations.
- Contact information.
Value
Competitive Activity – keep an eye on planned or ongoing trials, as well as the trials currently recruiting and who is sponsoring them.
Geographic Analysis - see where trials are being run.
Trend Analysis - view top sponsors, indications, phase, status and more with Trial Analytics.
Find information on trials contacts, as well as Site and Investigator information.
Get information on trial successes and failures.
Get intelligence on CROs engaged in clinical trials.
Use as a business development tool for CROs.
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer